Are asthma and chronic obstructive pulmonary disease different diseases? - Con

Monaldi Archives for Chest Disease

Volumn 54, Issue 6, 1999, Pages 551-558

  Ten Hacken, N H T ^a   Postma, D S ^a   Timens, W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Discrepancies; Pathology; Similarities

Indexed keywords

BRONCHOCONSTRICTING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

AIRWAY OBSTRUCTION; ASTHMA; ATOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; COUGHING; EOSINOPHIL; HUMAN; HYPERSENSITIVITY REACTION; MAST CELL; RESPIRATORY TRACT INFLAMMATION; SMOKING; SPUTUM; WHEEZING;

EID: 0033376236     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (70)

1. Orie NGM, Sluiter HJ, De Vries H, et al. - The host factors in bronchitis. In: Orie NGM, Sluiter HJ, eds. Bronchitis, an international symposium. Assen, Royal van Gorcum, 1961; p. 43-59.
2. Sluiter HJ, Koëter G, de Monchy JG, Postma DS, De Vries K, Orie NGM. - The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J 1991; 4: 479-489.
3. Jeffery PK. - Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: S6-13.
4. Magnussen H, Richter K, Taube C. - Are chronic obstructive pulmonary diseases (COPD) and asthma different diseases? Clin Exp Allergy 1998; 28: 187-194.
5. Saetta M. - Airway pathology of COPD compared with asthma. Eur Respir Rev 1997; 7: 211-215.
6. Jeffery PK. - Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998; 53: 129-136.
7. Riess A, Wiggs B, Verburgt L, Wright JL, Hogg JC, Pare PD. - Morphologic determinants of airway responsiveness in chronic smokers. Am J Respir Crit Care Med 1996; 154: 1444-1449.
8. Postma DS, Kerstjens HA. - Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: S187-S192.
9. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. - Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140: 1527-1537.
10. Lacoste JY, Bousquet J, Chanez P, et al. - Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92: 537-548.
11. Linden M, Rasmussen JB, Piitulainen E, et al. - Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993; 148: 1226-1232.
12. Ulrik CS, Backer V, Dirksen A. - A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47: 14-18.
13. Postma DS, Lebowitz MD. - Rate of decline of lung function in subjects with asthma. Arch Intern Med 1995; 155: 1393-1399.
14. Schayck CP van, Dompeling E, Van HC, Wever AM, Van WC. - Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991; 144: 1297-1301.
15. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. - A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-1200.
16. Ulrik CS, Lange P. - Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150: 629-634.
17. Postma DS, De Vries K, Koëter GH, Sluiter HJ. - Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis 1986; 134: 276-280.
18. Kerstjens HAM, Brand PLP, Postma DS. - Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: S266-S272.
19. Anthonisen NR, Connett JE, Kiley JP, et al. - Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994; 272: 1497-1505.
20. Rijcken B, Britton J. - Epidemiology of chronic obstructive pulmonary disease. In: Postma DS, Siafakas NM, eds. Management of chronic obstructive pulmonary disease. Huddersfield, Charlesworth Group, 1998; Chap. 5, p. 41-73.
21. Paganin F, Seneterre E, Chanez P, et al. - Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996; 153: 110-114.
22. Biernacki W, Redpath AT, Best JJK, Macnee W. - Measurement of CT lung density in patients with chronic asthma. Eur Respir J 1997; 10: 2455-2459.
23. Kondoh Y, Taniguchi H, Yokoyama S, Taki F, Takagi K, Satake T. - Emphysematous change in chronic asthma in relation to cigarette smoking. Assessment by computed tomography. Chest 1990; 97: 84-59.
24. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. - Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 1505-1510.
25. Carroll N, Lehmann E, Barret J, Morton A, Cooke C, James A. - Variability of airway structure and inflammation in normal subjects and in cases of nonfatal and fatal asthma. Pathol Res Pract 1996; 192: 238-248.
26. Hamid Q, Song Y, Kotsimbos TC, et al. - Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100: 44-51.
27. Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G. - Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996; 51: 1000-10004.
28. Fahy JV, Kim KW, Liu J, Boushey HA. - Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95: 843-852.
29. Pizzichini MM, Pizzichini E, Efthimiadis A, et al. - Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998; 158: 1178-1184.
30. Lamblin C, Gosset P, Tillie LI, Saulnier F, Marquette CH, Wallaert B, Tonnel AB. - Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998; 157: 394-402.
31. Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW. - Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 1986; 89: 477-483.
32. 3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986; 60: 1321-1326.
33. Fabbri LM, Boschetto P, Zocca E, et al. - Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis 1987; 136: 36-42.
34. Keatings VM, Collins PD, Scott DM, Barnes PJ. - Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
35. Nocker RE, Schoonbrood DF, van-de GE, et al. - Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 1996; 109: 183-191.
36. Yamamoto C, Yoneda T, Yoshikawa M, et al. - Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997; 112: 505-510.
37. Calhoun WJ, Jarjour NN, Gleich GJ, ,Stevens CA, Busse WW. - Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis 1993; 147: 1465-1471.
38. Rankin JA. - The contribution of alveolar macrophages to hyperreactive airway disease. J Allergy Clin Immunol 1989; 83: 722-729.
39. Calhoun WJ, Reed HE, Moest DR, Stevens CA. - Enhanced Superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1992; 145: 317-325.
40. Carroll N, Elliot J, Morton A, James A. - The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993; 147: 405-410.
41. Calverley PM, Georgopoulos D. Chronic obstructive pulmonary disease: symptoms and signs. Postma DS, Siafakas NM, eds. Management of chronic obstructive pulmonary disease. Huddersfield, Charlesworth Group, 1998; Chap. 3, p. 6-24.
42. Dompeling E, Schayck CP van, Molema J, Folgering H, van Grunsveld PM, van Weel C. - Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J 1992; 5: 945-952.
43. Kerstjens HAM, Brand PLP, Hughes MD, et al. - A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327: 1413-1419.
44. Thompson WH, Nielson CP, Carvalho NB, Crowley JJ. - Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154: 407-412.
45. Pesci A, Rossi GA, Bertorelli G, Aufiero A, Zanon P, Olivieri D. - Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis. Am J Respir Crit Care Med 1994- 149: 1311-1316.
46. Grashoff WF, Sont JK, Sterk PJ, et al. - Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol 1997; 151: 1785-1790.
47. Rutgers SR, Timens W, Kauffman HF, van der Mark ThW, Koëter GH, Postma DS. Induced sputum represents different aspects of airway inflammation than bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 1999; (in press).
48. Saetta M, Di Stefano A, Maestrelli P, et al. - Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150: 1646-1652.
49. Hoshi H, Ohno I, Honma M, et al. - IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis. Clin Exp Allergy 1995; 25: 720-728.
50. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. - Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
51. Fujimoto K, Kubo K, Yamamoto H, Yamaguchi S, Matsuzawa Y. - Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 1999; 115: 697-702.
52. Mattoli S, Kleimberg J, Stacey MA, Bellini A, Sun G, Marini M. - The role of CD8+ Th2 lymphocytes in the development of smoking-related lung damage. Biochem Biophys Res Commun 1997; 239: 146-149.
53. Wright RR, Stuart CM. - Chronic bronchitis with emphysema: a pathological study of the bronchi. Med Thoracalis 1965; 22: 210-219.
54. Klienerman J, Boren HG. - Morphologic basis of chronic obstructive lung disease. In: Baum GL, eds. Textbook of pulmonary disease. Boston, Little Brown Company, 1974; p. 571-576.
55. Ailsby RL, Ghadially FN. - Atypical cilia in human bronchial mucosa. J Pathol 1973; 109: 75-78.
56. Vignola AM, Chanez P, Chiappara G, et al. - Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 591-599.
57. Vignola AM, Riccobono L, Mirabella A, et al. - Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158: 1945-1950.
58. Bossé M, Chakir J, Rouabhia M, Boulet LP, Audette M, Laviolette M. - Serum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999; 159: 596-602.
59. Gyetko MR, Toews GB. - Immunology of the aging lung. Clin Chest Med 1993; 14: 379-391.
60. Cutz E, Levison H, Cooper DM. - Ultrastructure of airways in children with asthma. Histopathology 1978; 2: 407-421.
61. Pohunek P, Roche WR, Urzikova J, Kudrmann J, Warner JO. - Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur J Respir Dis 1997; 10: 160S.
62. Niewoehner D, Kleinerman J, Rice D. - Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 278: 1355-1360.
63. Fletcher C, Peto R. - The natural history of chronic airflow obstruction. BMJ 1977; 1 (i): 1645-1648.
64. Panhuysen CI, Vonk JM, Koëter GH, et al. - Adult patients may outgrow, their asthma: a 25-year follow-up study. Am J Respir Crit Care Med 1997; 155: 1267-1272.
65. Postma DS, Bleecker ER, Amelung PJ, et al. - Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333: 894-900.
66. Meyers DA, Xu J, Postma DS, Levitt RC, Bleecker ER. - Two locus segregation and linkage analysis for total serum IgE levels. Clin Exp Allergy 1995; 25: Suppl 2, 113-115.
67. Sandford AJ, Weir TD, Pare PD. - Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 1380-1391.
68. Silverman EK, Chapman HA, Drazen JM, et al. - Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998; 157: 1770-1778.
69. Luisetti M, Pignatti PF. - The search for susceptibility genes of COPD. Monaldi Arch Chest Dis 1995; 50: 28-32.
70. Holgate ST. - The cellular and mediator basis of asthma in relation to natural history. Lancet 1997; 350: Suppl. 2, S115-S119.